Turning on the off switch: Regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway

Journal of Hepatology

Volumn 45, Issue 4, 2006, Pages 468-472

  Grakoui, Arash ^a,b   John Wherry, E ^c   Hanson, Holly L ^a   Walker, Christopher ^d   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WISTAR INSTITUTE   (United States)

^d Children's Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2 INTERFERON; ANTIVIRUS AGENT; BLOCKING ANTIBODY; CD28 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERFERON; LAMIVUDINE; PEGINTERFERON; PROTEIN PD 1; PROTEIN PD L1; RECEPTOR; RIBAVIRIN; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW CELL; CELL DEATH; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; DOWN REGULATION; EDITORIAL; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MICROORGANISM DETECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; UNSPECIFIED SIDE EFFECT; UPREGULATION; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, CD; HUMANS; LIVER; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 33748113465     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.07.009     Document Type: Editorial

References (31)

1. Klenerman P., and Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 6 (2005) 873-879
2. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
3. Bowen D.G., and Walker C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436 (2005) 946-952
4. Rothstein D.M., and Sayegh M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196 (2003) 85-108
5. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu Rev Immunol 23 (2005) 515-548
6. Mühlbauer M., Fleck M., Schütz C., Weiss T., Froh M., Blank C., et al. PD-L1 is induced by viral infection and by interferon-α and -γ and mediates T cell apoptosis. J Hepatol 45 (2006) 520-528
7. Egen J.G., Kuhns M.S., and Allison J.P. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3 (2002) 611-618
8. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1 (1994) 405-413
9. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., and Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3 (1995) 541-547
10. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270 (1995) 985-988
11. Ishida Y., Agata Y., Shibahara K., and Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11 (1992) 3887-3895
12. Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8 (1996) 765-772
13. Zhang X., Schwartz J.C., Guo X., Bhatia S., Cao E., Lorenz M., et al. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20 (2004) 337-347
14. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2 (2001) 261-268
15. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., et al. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32 (2002) 634-643
16. Okazaki T., Maeda A., Nishimura H., Kurosaki T., and Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 98 (2001) 13866-13871
17. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 33 (2003) 2706-2716
18. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192 (2000) 1027-1034
19. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5 (1999) 1365-1369
20. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193 (2001) 839-846
21. Tamura H., Dong H., Zhu G., Sica G.L., Flies D.B., Tamada K., et al. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97 (2001) 1809-1816
22. Tamura H., Ogata K., Dong H., and Chen L. Immunology of B7-H1 and its roles in human diseases. Int J Hematol 78 (2003) 321-328
23. Wang S., Bajorath J., Flies D.B., Dong H., Honjo T., and Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med 197 (2003) 1083-1091
24. Loke P., and Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci USA 100 (2003) 5336-5341
25. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
26. Dong H., Zhu G., Tamada K., Flies D.B., van Deursen J.M., and Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20 (2004) 327-336
27. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3 (2003) 51-62
28. Iwai Y., Terawaki S., Ikegawa M., Okazaki T., and Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 198 (2003) 39-50
29. Isogawa M., Furuichi Y., and Chisari F.V. Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity 23 (2005) 53-63
30. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169 (2002) 5538-5545
31. Reichard O., Schvarcz R., and Weiland O. Therapy of hepatitis C: alpha interferon and ribavirin. Hepatology 26 (1997) 108S-111S